ピペクロニウム臭化物(52212-02-9)

ChemicalBook Optimization Suppliers
名前: Jinan Good Medical &Technology Ltd Co.,  Gold
電話番号: +86-0086-531-55562571,18953105926 +86-13553167512
電子メール: 935170726@qq.com
名前: Shandong RuiYue Biotechnology Co., Ltd.  Gold
電話番号: 0531-88581623 18805314509
電子メール: 1456922171@126.com
名前: J & K SCIENTIFIC LTD.  
電話番号: 010-82848833 400-666-7788
電子メール: jkinfo@jkchemical.com
名前: Chembest Research Laboratories Limited  
電話番号: 021-20908456
電子メール: sales@BioChemBest.com
名前: JinYan Chemicals(ShangHai) Co.,Ltd.  
電話番号: 13817811078
電子メール: sales@jingyan-chemical.com
ピペクロニウム臭化物 製品概要
化学名:ピペクロニウム臭化物
英語化学名:Pipecuronium bromide
别名:pipecuronium bromide;4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)androstane-2,16-diyl)bis(1,1-dimethyl-piperazinium) dibromide;4,4'-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetoxy)androstane-2,16-diyl]bis[1,1-dimethylpiperazinium] dibromide;PIPECURIUM BROMIDE;PIPECURINIUM BROMIDE;4,4’-[(2β,3α,5α,16β,17β)-3,17-Bis(acetoxy)andrc~tane-2,16-diyl]bis(1,1-dimethylpiperazinium)dibromide;Ardtm;Pipecuriurn Brmnide
CAS番号:52212-02-9
分子式:C35H62Br2N4O4
分子量:762.69918
EINECS:257-740-4
カテゴリ情報:
Mol File:52212-02-9.mol
ピペクロニウム臭化物
ピペクロニウム臭化物 物理性質
融点 262-264° (dec)
比旋光度 D25 +8.1° (c = 1 in water)
貯蔵温度 Store at -20°C
溶解性DMSO, Methanol (Slightly), Water (Slightly)
外見 Solid
White to Off-White
CAS データベース52212-02-9(CAS DataBase Reference)
安全性情報
毒性LD50 in mice, rats (mg/kg): 29.7, 172.6 i.v.; 70.6, 449.6 i.p.; 60.5, 455.8 s.c. (Kárpáti, Biro)
ピペクロニウム臭化物 Usage And Synthesis
効能神経筋遮断薬
使用Pipecuronium Bromide is a muscle relaxant and an anaesthesia used in patients undergoing coronary artery bypass graft surgery.
定義ChEBI: Pipecuronium bromide is a steroid ester.
brand nameArduan (Organon).
一般的な説明Pipecurium bromide, 4,4 -(3 ,17 -dihydroxy-5 -androstan-2 ,16 -ylene)bis(1,1-dimeth-ylpiperazinium)dibromide diacetate (Arduan), is anondepolarizing muscle relaxant similar, both chemicallyand clinically, to pancuronium bromide. It is a long-actingdrug indicated as an adjunct to anesthesia and in patients undergoingmechanical ventilation.
薬理学Pipecuronium bromide, an analogue of pancuronium, was developed in Hungary in 1980 and is marketed in Eastern Europe and the United S tates. The intubating dose is 0.07 mg kg–1. The onset time and time to recovery from block are similar to those of pancuronium, and excretion of the drug through the kidneys is significant (66%). In contrast to pancuronium, pipecuronium produces marked cardiovascular stability, having no vagolytic or sympathomimetic effects. It may therefore be useful during major surgery in patients with cardiac disease.
Tags:52212-02-9